Manufacturer-Level Pharmaceutical Sourcing or Substitution Support

The contract authorizes the supply of Scopolamine Transdermal patches under the Defense Logistics Agency's medical substitution rules, ensuring alignment with established pharmaceutical substitution protocols. Only manufacturers with approved CAGE codes are permitted to participate, and all products must strictly conform to the National Stock Number and RANK specifications to maintain regulatory compliance and operational readiness. This is a subcontract under the broader Manufacturer-Level Pharmaceutical Sourcing or Substitution Support framework, targeting the secure and standardized procurement of critical medical countermeasures for military healthcare systems. The obligation is governed by the Department of Defense through the Defense Logistics Agency, with the NAICS code 325412 indicating the industry classification as Pharmaceutical and Biological Product Manufacturing. The contract was posted on July 14, 2026, and is accessible via the DIBBS system with the contract and delivery order identifiers SPE2DX25D9900 and SPE2DP26F7514, respectively. While specific performance locations and point of contact details are not provided, the terms require adherence to federal procurement standards and ensure seamless integration into the military’s medical supply chain.